|
⚲
|
| Keyboard |
| Galletta Christopher
✚
|
|
|---|---|
| CIK # | 0001486099 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001486099] | |
| 4 | [0001486099] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Trevi Therapeutics Inc | |
| Galletta Christopher | |
| Transact Technologies Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Trevi Therapeutics Inc TRVI
Stock Option (right to buy) · derivative
|
2026-02-19 | Grant | 35,000 | $0.00 | |
|
Trevi Therapeutics Inc TRVI
Stock Option (right to buy) · derivative
|
2025-12-02 | Option exercise | 4,225 | $0.00 | |
|
Trevi Therapeutics Inc TRVI
Common Stock
|
2025-12-02 | Option exercise | 4,225 | $0.51 | 2,155 |
|
Trevi Therapeutics Inc TRVI
Performance Stock Option (right to buy) · derivative
|
2025-05-31 | Grant | 8,550 | $0.00 | |
|
Trevi Therapeutics Inc TRVI
Performance Stock Option (right to buy) · derivative
|
2025-03-10 | Grant | 4,560 | $0.00 | |
|
Trevi Therapeutics Inc TRVI
Stock Option (right to buy) · derivative
|
2025-02-18 | Grant | 41,000 | $0.00 | |
|
Trevi Therapeutics Inc TRVI
Stock Option (right to buy) · derivative
|
2024-12-13 | Option exercise | 15,000 | $0.00 | |
|
Trevi Therapeutics Inc TRVI
Common Stock
|
2024-12-13 | Option exercise | 15,000 | $0.51 | 7,650 |
|
Trevi Therapeutics Inc TRVI
Stock Option (right to buy) · derivative
|
2024-02-15 | Grant | 28,500 | $0.00 | |
|
Trevi Therapeutics Inc TRVI
Stock Option (right to buy) · derivative
|
2023-02-16 | Grant | 40,000 | $0.00 | |
|
Trevi Therapeutics Inc TRVI
Stock Option (right to buy) · derivative
|
2022-02-11 | Grant | 35,000 | $0.00 | |
|
Trevi Therapeutics Inc TRVI
Stock Option (right to buy) · derivative
|
2021-04-13 | Grant | 25,000 | $0.00 | |
|
Transact Technologies Inc TACT
Common Stock
|
2012-01-02 | Option exercise | 500 | $2.18 | 1,090 |
|
Transact Technologies Inc TACT
Stock Option · derivative
|
2012-01-02 | Option exercise | 500 | $2.18 | 1,090 |